Carbon dioxide laser treatment of lichen sclerosus et atrophicus.
We followed 62 men treated with the carbon dioxide laser for lichen sclerosus et atrophicus for an average of 30 months (3 months to 7 years). Of the patients 47 (76%) became asymptomatic and 10 (16%) had minor residual symptoms. In 26 patients (40%) concomitant superficial meatal stenosis was simultaneously treated with laser meatotomy. The cosmetic and functional results of treatment were highly encouraging. Provided that radicality is achieved at the primary application, the carbon dioxide laser is an excellent therapeutic modality for lichen sclerosus et atrophicus.
Windahl
T
T
Department of Urology, Orebro Medical Center Hospital, Orebro and General Hospital, Malmö, Sweden.
Hellsten
S
S
D000328:Adult; D000368:Aged; D002245:Carbon Dioxide; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy; D017512:Lichenoid Eruptions / Q000601:surgery*; D008297:Male; D008875:Middle Aged
D002245:Carbon Dioxide